1. Home Page
  2. Find a Scientific Publication
  3. Who Will Benefit Using Radiomics To Predict Response To Oxaliplatinbased Chemotherapy In Patients With Colorectal Liver Metastases
Ann Surg Oncol in press

Who Will Benefit? Using Radiomics to Predict Response to Oxaliplatin-
Based Chemotherapy in Patients with Colorectal Liver Metastases.

January 21, 2021 at 12:00 AM

Hewitt DB, Pawlik TM, Cloyd JM